Abstract
It is known that C57BL/6, C57BL/10 and SJL mice are high responders to intravenously injected BCG cell-wall vaccine or oil-treated BCG organisms, whereas C3H, DBA/1 and DBA/2 mice are low responders. In a previous study, we found that C3H mice produced extensive lung granuloma when they were primed subcutaneously with BCG cell-wall vaccine and later rechallenged intravenously with the same vaccine. Now, we report that DBA/1 mice, but not DBA/2 mice, did not respond to intravenously challenged BCG cell-wall vaccine, even if this priming-rechallenging protocol is used. Thus, the low responders to the BCG cell-wall vaccine are divided into two groups. Breeding experiments using DBA/1 mouse as a parent suggest that an X-linked gene might control the responsiveness to BCG cell-wall vaccine in vivo.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allen E. M., Moore V. L., Stevens J. O. Strain variation in BCG-induced chronic pulmonary inflammation in mice. I. Basic model and possible genetic control by non-H-2 genes. J Immunol. 1977 Jul;119(1):343–347. [PubMed] [Google Scholar]
- Kakinuma M., Onoé K., Yasumizu R., Yamamoto K. Strain differences in lung granuloma formation in response to a BCG cell-wall vaccine in mice. Failure of antigen presentation by low-responder macrophages. Immunology. 1983 Nov;50(3):423–431. [PMC free article] [PubMed] [Google Scholar]
- Yamamoto K., Karinuma M. Genetic control of granuloma response to oil-associated BCG cell wall vaccine in mice. Microbiol Immunol. 1978;22(6):335–348. doi: 10.1111/j.1348-0421.1978.tb00378.x. [DOI] [PubMed] [Google Scholar]